Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02697487 · ClinicalTrials.gov registry record
UTSW Depression Cohort: A Longitudinal Study of Depression
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 447
- Enrollment target
NCT02697487: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT02697487 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 447 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02697487 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 447 participants
- Enrollment target
Study Summary
This is a longitudinal observational study (via electronic records and biospecimens) designed to utilize health IT advances to collect information from patients undergoing routine care. This information will be stored in a database. Patients undergoing routine care from their providers will be invited to participate in the UTSW Depression Cohort. After obtaining informed consent, the CDRCC team will collect information from available sources and store it in a secure UT Southwestern network database protected by a security firewall. A schematic representation of this information processing is shown in the figure contained in section 3 of the protocol. As part of the UTSW Depression Cohort, patients will allow banking of their specimens. Specimens which are banked may include blood or blood products, urine, tissue samples, saliva, stool samples or clinical waste products. The study will only enroll participants comfortable with providing specimens. As the goal of the UTSW Depression Cohort is to create a national database, CDRCC will engage with patients, providers, and researchers at local, regional, and national levels. A large number of medical providers are already screening patients for depression. Structured instruments like PHQ-2 or PHQ-9 are often used. Hence, the CDRCC will seek collaborations with local, regional and national partners so that information contained in their health IT initiatives can be included in the this database. Due to the clinical nature of information collected, the investigators anticipate marked heterogeneity in the variables and amount of data collected. Database architects will utilize big data (large volumes of information from diverse sources with variable degrees of quality and complexity) tools to structure the registry so that additional variables can be added, as needed. The CDRCC team will maintain a detailed codebook of variables collected in the database. All statistical analyses will be conducted only on de-identified data
Primary Outcome
Changes in depression severity will be measured by 9-item Patient Health Questionnaire. PHQ-9 score ranges from 0-27, higher score indicates sever depression. Minimal depression 0-4 Mild depression 5-9 Moderate depression 10-14 Moderately severe depression 15-19 Severe depression 20-27
Interventions
- OTHER No treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-03-22 |
What the finished NCT02697487 record still lists
NCT02697487 is an observational study that tracks outcomes without assigning an intervention. The registered 447 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No treatment is the first listed.
NCT02697487 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02697487 about?
NCT02697487 is a clinical study titled "UTSW Depression Cohort: A Longitudinal Study of Depression". This is a longitudinal observational study (via electronic records and biospecimens) designed to utilize health IT advances to collect information from patients undergoing routine care. This information will be stored in a database. Patients undergoing routine care from their providers will be invit...
What is the current status of trial NCT02697487?
This trial is currently completed. The enrollment target is 447 participants. The study started on 2016-02. Estimated completion is 2018-03-22.
What interventions are being tested in trial NCT02697487?
The interventions under investigation include: No treatment (OTHER).
Who is sponsoring clinical trial NCT02697487?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia